Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG)

dc.authoridAladag, Elifcan/0000-0002-1206-9908
dc.authoridalbayrak, murat/0000-0003-4025-741X
dc.authoridYılmaz, Mehmet/0000-0002-4368-8453
dc.authoridYILMAZ, Mehmet/0000-0002-5710-5263
dc.authoridÖZDOĞU, HAKAN/0000-0002-8902-1283
dc.authoridKoca, Ebru/0000-0002-7566-4456
dc.authoridKaynar, Leylagul/0000-0002-2035-9462
dc.authorwosidAladag, Elifcan/ABA-4185-2020
dc.authorwosidalbayrak, murat/K-7879-2019
dc.authorwosidGunduz, Eren/AAA-4354-2021
dc.authorwosidÖzkan, Hasan Atilla/GWQ-9284-2022
dc.authorwosidYılmaz, Mehmet/HTO-6056-2023
dc.authorwosidBesısık, Sevgi/AAD-6628-2020
dc.authorwosidYILMAZ, Mehmet/HKM-4739-2023
dc.contributor.authorTekgunduz, Emre
dc.contributor.authorDemirkan, Fatih
dc.contributor.authorVural, Filiz
dc.contributor.authorGoker, Hakan
dc.contributor.authorOzdogu, Hakan
dc.contributor.authorKiki, Ilhami
dc.contributor.authorAydogdu, Ismet
dc.date.accessioned2024-08-04T20:44:06Z
dc.date.available2024-08-04T20:44:06Z
dc.date.issued2017
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAutologous hematopoietic cell transplantation (AHCT) is an established treatment option for adult patients presenting with multiple myeloma (MM), Hodgkin lymphoma (HL) and various subtypes of non-Hodgkin lymphoma (NHL) in upfront and/or relapsed/refractory disease settings. Although there are recently published consensus guidelines addressing critical issues regarding autologous hematopoietic progenitor cell mobilization (HPCM), mobilization strategies of transplant centers show high variability in terms of routine practice. In order to understand the current institutional policies regarding HPCM in Turkey and to obtain the required basic data for preparation of a national positional statement on this issue, Turkish Hematology Research and Education Group (ThREG) conducted a web-based HPCM survey. The survey was designed to include multiple-choice questions regarding institutional practice of HPCM in adults presenting MM, HL, and NHL. The representatives of 27 adult HCT centers participated to the study. Here we report the results of this survey shedding light on the real world experience in Turkey in terms of autologous HPCM mobilization strategies in patients presenting with MM and lymphoma. (C) 2017 Elsevier Ltd. All rights reserved.en_US
dc.identifier.doi10.1016/j.transci.2017.11.010
dc.identifier.endpage808en_US
dc.identifier.issn1473-0502
dc.identifier.issue6en_US
dc.identifier.pmid29153305en_US
dc.identifier.scopus2-s2.0-85033796844en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage804en_US
dc.identifier.urihttps://doi.org/10.1016/j.transci.2017.11.010
dc.identifier.urihttps://hdl.handle.net/11616/98024
dc.identifier.volume56en_US
dc.identifier.wosWOS:000423246100009en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.ispartofTransfusion and Apheresis Scienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAutologous hematopoietic cell transplantationen_US
dc.subjectLymphomaen_US
dc.subjectMyelomaen_US
dc.subjectMobilizationen_US
dc.titleCurrent practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG)en_US
dc.typeArticleen_US

Dosyalar